Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Pharmacokinetic–Pharmacodynamic Relationship: Model Components01:14

Pharmacokinetic–Pharmacodynamic Relationship: Model Components

Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreased cigarette smoking may partially explain the increased prevalence of antinuclear antibodies in the United States.

Frontiers in immunology·2025
Same author

Comparison of overnight trends in relative power for specific frequency bands, sleep stages, and brain regions between patients with depressive disorder and matched control subjects.

Psychiatry research. Neuroimaging·2025
Same author

Age Trajectories of O<sub>2</sub> Saturation and Levels of Serum Bicarbonate or End-Tidal CO<sub>2</sub> Across the Life Course of Women and Men: Insights from EHR and PSG Data.

Biomolecules·2025
Same author

A method for finding epistatic effects of maternal and fetal variants.

Frontiers in genetics·2025
Same author

Lessons learned from evaluating defined chemical mixtures in a high-throughput estrogen receptor assay system.

Toxicological sciences : an official journal of the Society of Toxicology·2025
Same author

Sex- and age-differences in supine positional obstructive sleep apnea in children and adults.

Sleep & breathing = Schlaf & Atmung·2025
Same journal

A fond farewell to Jeffrey Peters, editor-in-chief of ToxSci.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

Aryl hydrocarbon Receptor Nuclear Translocator 2: A Forgotten Per-ARNT-Sim Transcription Factor.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

ToxMet: a web tool for toxicogenomic data analysis using genome-scale metabolic modeling.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

T-cell chromatin states reflect individual differences in ex vivo cytokine release and cytotoxicity induced by T-cell engager ERY22 in cynomolgus monkeys.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

DILI-Context: A Dose- and Exposure-Enriched Knowledge Base for Translational Liver Safety Assessment.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same journal

MEHP exposure damages the basement membrane by suppressing the expression of its constituent proteins in peritubular myoid cells of the rat testis.

Toxicological sciences : an official journal of the Society of Toxicology·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Parallel Interrogation of &#946;-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Parameterizing dose-response models to estimate relative potency functions directly.

Gregg E Dinse1, David M Umbach

  • 1Biostatistics Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA. dinse@niehs.nih.gov

Toxicological Sciences : an Official Journal of the Society of Toxicology
|June 16, 2012
PubMed
Summary
This summary is machine-generated.

This study introduces a direct method for estimating relative potency functions, improving toxicological analyses. This approach avoids misleading conclusions from assuming constant relative potency between chemicals.

More Related Videos

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Related Experiment Videos

Last Updated: May 21, 2026

Parallel Interrogation of &#946;-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Area of Science:

  • Toxicology
  • Pharmacometrics
  • Biostatistics

Background:

  • Comparative toxicity assessments often assume constant relative potency between chemicals, which can lead to inaccurate conclusions.
  • Existing methods estimate relative potency functions secondarily after fitting dose-response models, which can be complex.

Purpose of the Study:

  • To investigate an alternative approach for characterizing chemical potency by directly estimating relative potency functions.
  • To evaluate a priori relative potency models, specifically a power function, for direct estimation using combined dose-response data.

Main Methods:

  • Developed and applied a direct estimation method for relative potency models using nonlinear regression.
  • Utilized a power function as the relative potency model, ensuring dose-response functions remain within common toxicological model families.
  • Illustrated the approach with Hill models and data from U.S. National Toxicology Program (NTP) bioassays.

Main Results:

  • The direct estimation approach is straightforward when response limits do not differ or are due to experimental factors.
  • This method simplifies the calculation of simultaneous confidence bands for relative potency.
  • The power function model effectively integrates dose-response data from test and reference chemicals.

Conclusions:

  • Directly estimating relative potency functions offers a valuable alternative to secondary estimation methods in toxicology.
  • This approach enhances the accuracy and interpretability of comparative chemical potency assessments.
  • The method is broadly applicable across various dose-response models commonly used in toxicological research.